Pharmaceutical Market Europe • November 2025 • 3

COMMENT

ESMO 2025: 
‘Many journeys.
One global community’

This year, ESMO celebrated 50 years of bringing people together to explore advances and innovations in oncology research. In their article on page 16, Susanne Bobadilla and Costas Saratsis highlight that while “a flood of new data drew packed auditoriums, conversations about health equity, sustainability and communication reminded us that science only comes alive when it reaches people.

“More than 35,000 delegates packed into Messe Berlin for ESMO 2025, marking the congress’s 50th anniversary under the theme: ‘Many journeys. One global community.’ Over four days, 2,926 sessions charted oncology’s rapid progress – from paradigm-shifting data to the vital work of bringing innovation into everyday care.

“This wasn’t a nostalgic celebration; it was a declaration that oncology’s next era is already here. The energy was electric, the conversations constant. Everywhere you turned, the message was the same: discovery is only the beginning – what matters is how we translate it into the real world.” Turn to page 16 to find out more.

Also in this issue we have Part 2 of an article from Jon Gibbins and Chris Jones on clinical pathway management, looking at how personalising therapy promises to revolutionise the treatment of thrombosis.

As they say: “Cardiovascular diseases (CVDs) still account for about one-third of all deaths worldwide, totalling around 20 million deaths each year and affecting over 500 million people globally.

“Healthcare costs are enormous, with global spending expected to reach $1tn by 2030. Notably, low- and middle-income countries are disproportionately impacted by high rates of CVD mortality.

“Despite major improvements...CVD-related mortality and morbidity remain stubbornly high. We have effective drugs. So why are we stuck?” Find out more on page 20.

Our next issue, in December 2025, will look at how HCPs are harnessing social media to improve patient understanding. If you would like to make your voice heard on this topic, please get in touch at sales@pmlive.com.

I hope you enjoy this issue!

Image

Iona Everson
Group Managing Editor

Image

Keep up to date with the latest developments in the UK and global healthcare marketplace – sign up to daily or weekly news alerts and fortnightly or monthly bulletins on specific topics at  www.pmlive.com/register

Image

THE TEAM
Editorial:
Group Managing Editor
Iona Everson

Journalist/Editorial Assistant
Esme Needham


Studio:
Executive Director
Karl Equi

Sales:
Business Director
Tara Lovegrove

EDITORIAL ADVISORY BOARD
Philip Atkinson
Founder of Hive-Logic, Lifescience Transformation

Uday Bose
Corporate vice president, head of global marketing oncology, Boehringer Ingelheim

Dr Luc Hermans
VP commercial planning and operations Europe, Asia, Middle East, Gilead Sciences

Stefan Janssens
President EMEA, Cegedim Dendrite

John Morris
Partner, KPMG

Paul Pay
Chief business development officer, Norgine

Mark Rothera
Chief executive officer, Orchard Therapeutics

Ian Talmage
Senior vice president, global marketing, general medicine, Bayer Pharmaceuticals

PUBLISHED BY
PMGroup Worldwide Ltd
44 Maiden Lane
Covent Garden
London
WC2E 7LN


CONTACT US
General enquiries: info@pmlive.com
Editorial: editor@pmlive.com
Advertising: sales@pmlive.com
Subscriptions: subscriptions@pmlive.com

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

© 2025 PMGroup
All rights reserved. No part of this publication may be copied, reproduced, transmitted, photocopied, recorded or stored on any retrieval system without the prior written consent of the publishers.

The magazine is also available at the following subscription rates: £120 UK, £180 Europe, £210 RoW

Image